STEM CELLS ARABIA
π―π΄Jordan
- Country
- π―π΄Jordan
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://stemcellsarabia.net
Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells
Phase 1
- Conditions
- Use of Stem Cells for COVID-19 Treatment
- Interventions
- Biological: WJ-MSCs
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 5
- Registration Number
- NCT04313322
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy
Phase 1
- Conditions
- Cerebral Palsy
- Interventions
- Biological: Stem Cell Therapy
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 50
- Registration Number
- NCT03078621
Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)
Phase 1
- Conditions
- Premature Ovarian Failure
- Interventions
- Biological: Stem Cells
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 50
- Registration Number
- NCT03069209
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis.
Phase 1
- Conditions
- Multiple Sclerosis
- Interventions
- Biological: Stem Cell Transplantation
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 50
- Registration Number
- NCT03069170
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy
Phase 1
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Biological: Stem Cells
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 20
- Registration Number
- NCT03067831
- Locations
- π―π΄
Stem Cells of Arabia, Amman, Jordan
Transplantation of Autologous Bone Marrow Derived Stem Cells in Patients With Rheumatoid Arthritis
Phase 1
- Conditions
- RheumatoId ArthritisOsteoarthritis, KneeOsteoarthritis, Hip
- Interventions
- Biological: Stem Cell Transplantation
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 100
- Registration Number
- NCT03067870
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
Phase 1
- Conditions
- Amyotrophic Lateral SclerosisMotor Neuron DiseaseProgressive Muscular AtrophyProgressive Bulbar PalsiesPrimary Lateral Sclerosis
- Interventions
- Biological: Stem Cells
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 40
- Registration Number
- NCT03067857
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa
Phase 1
- Conditions
- Retinitis Pigmentosa
- Interventions
- Biological: Stem Cell Transplantation
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 50
- Registration Number
- NCT02709876
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Transplantation of Autologous Bone Marrow or Leukapheresis-Derived Stem Cells for Treatment of Spinal Cord Injury
Phase 2
- Conditions
- Spinal Cord Injury
- Interventions
- Biological: Stem Cell Transplantation
- First Posted Date
- 2016-02-22
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 50
- Registration Number
- NCT02687672
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Endocrine System DiseasesDiabetes Mellitus Type 1Glucose Metabolism DisordersImmune System DiseasesMetabolic DiseasesAutoimmune Diseases
- Interventions
- Biological: Stem Cell Transplantation
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Stem Cells Arabia
- Target Recruit Count
- 100
- Registration Number
- NCT02644759
- Locations
- π―π΄
Stem Cells Arabia, Amman, Jordan
Β© Copyright 2025. All Rights Reserved by MedPath